Arch Biopartners, Inc. (ARCH.V)
1.07
-0.09
(-7.76%)
CAD |
TSXV |
Aug 25, 15:59
Arch Biopartners Market Cap : 72.47M for Aug. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 78.56M |
| August 21, 2026 | 75.85M |
| August 20, 2026 | 68.40M |
| August 19, 2026 | 74.50M |
| August 18, 2026 | 77.89M |
| August 17, 2026 | 73.82M |
| August 14, 2026 | 75.18M |
| August 13, 2026 | 77.89M |
| August 12, 2026 | 74.50M |
| August 11, 2026 | 73.82M |
| August 10, 2026 | 79.24M |
| August 07, 2026 | 71.79M |
| August 06, 2026 | 61.63M |
| August 05, 2026 | 62.99M |
| August 04, 2026 | 56.89M |
| July 31, 2026 | 54.86M |
| July 30, 2026 | 57.57M |
| July 29, 2026 | 58.24M |
| July 28, 2026 | 58.24M |
| July 27, 2026 | 57.57M |
| July 24, 2026 | 58.92M |
| July 23, 2026 | 59.60M |
| July 21, 2026 | 58.24M |
| July 20, 2026 | 57.57M |
| July 17, 2026 | 56.89M |
| Date | Value |
|---|---|
| July 16, 2026 | 57.57M |
| July 15, 2026 | 57.57M |
| July 14, 2026 | 56.89M |
| July 13, 2026 | 56.21M |
| July 10, 2026 | 58.24M |
| July 09, 2026 | 55.54M |
| July 08, 2026 | 55.54M |
| July 07, 2026 | 53.50M |
| July 06, 2026 | 53.50M |
| July 03, 2026 | 62.31M |
| July 02, 2026 | 58.24M |
| June 30, 2026 | 53.50M |
| June 29, 2026 | 54.86M |
| June 26, 2026 | 64.34M |
| June 25, 2026 | 60.28M |
| June 24, 2026 | 71.11M |
| June 23, 2026 | 67.05M |
| June 22, 2026 | 56.89M |
| June 19, 2026 | 45.38M |
| June 18, 2026 | 42.67M |
| June 17, 2026 | 34.54M |
| June 16, 2026 | 33.19M |
| June 15, 2026 | 33.19M |
| June 12, 2026 | 34.54M |
| June 11, 2026 | 32.17M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Innovotech, Inc. | 4.355M |
| Kane Biotech, Inc. | 4.546M |
| Quest PharmaTech, Inc. | 3.383M |
| BriaCell Therapeutics Corp. | 37.27M |
| Vaxil Bio Ltd. | 0.6374M |
Market Cap Related Metrics
| Price | 1.07 |
| Earnings Yield | -3.66% |